BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Q, Yang H, Zhu X, Xiong S, Chi H, Xu W. Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression. Front Genet 2020;11:566. [PMID: 32547604 DOI: 10.3389/fgene.2020.00566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Geng Q, Wei Q, Shen Z, Zheng Y, Wang L, Xue W, Li L, Zhao J. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma. Cancer Manag Res 2021;13:7989-8002. [PMID: 34707405 DOI: 10.2147/CMAR.S331549] [Reference Citation Analysis]
2 Lainetti PF, Leis-Filho AF, Laufer-Amorim R, Battazza A, Fonseca-Alves CE. Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems. Pharmaceutics 2020;12:E1193. [PMID: 33316872 DOI: 10.3390/pharmaceutics12121193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]